查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446533

類器官和球體市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2024-2030 年

Organoids And Spheroids Market Size, Share & Trends Analysis Report By Type (Neurospheres, iPSCs Derived Cells, Hepatic Organoids), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

類器官和球體市場成長和趨勢：

根據Grand View Research, Inc.的最新報告，預計到2030年，全球類器官和球體市場規模將達到32.6億美元，預測期內複合年成長率為23.11%。

預計在藥物發現中擴大採用類器官培養以及全球整體對細胞治療和組織工程的需求不斷成長將推動該市場的發展。

3D 球體被認為是組織工程和再生醫學研究的重要方面，因為它們可以用作生成複雜組織和器官的構建塊。此外，3D細胞培養有潛力用於藥物篩檢和作為人類疾病的分析模型，預計在不久的將來將為市場提供充足的成長機會。

隨著使用類器官培養來評估人類特定疾病機制的勢頭不斷增強，預計該市場將會成長。例如，人類類器官可用於分析多種組織，包括小腸、前列腺、大腦和肝臟。類似於人體器官的 3D 細胞培養物的產生為使用類器官作為細胞療法和作為整個器官移植的潛在替代方案提供了巨大的潛力。

類器官和球體市場報告亮點

  • 預計球體部分將在整個分析期間主導市場。
  • 3D 球體在藥物發現、疾病建模和安全測試中的日益採用是推動該領域發展的關鍵因素。
  • 利用誘導性多功能幹細胞（iPSC）開發類器官，為細胞發育的動態觀察鋪平了道路，並推動了人類發育機制研究的採用，使發育生物學應用領域收益佔有率。
  • 在2023年的市場中，生物技術和製藥產業在最終用途領域佔據主導地位。這是由於製藥公司在臨床前藥物發現中高度利用類器官和球體。
  • 此外，這些公司正在積極致力於開發先進產品，以提高類器官和球體生產的效率。
  • 在北美，由於技術先進的細胞培養平台的採用率很高，並且有許多大學和學術機構積極從事利用細胞和器官的研究，因此該市場將在2023年達到最高水平，我們收益了。
  • 此外，北美地區類器官和球體培養產品的採用率很高，並且擁有高效的醫療基礎設施，這也是該地區銷售量最大的因素。
  • 在亞太地區，預計市場在預測期內將出現良好的成長。
  • STEMCELL Technologies、澳洲幹細胞研究協會 (ASSCR)、日本再生醫學協會和韓國幹細胞研究協會 (KSSCR) 等主要企業和政府機構的存在提高了類器官和球體培養在亞洲的滲透率預計
  • 各大公司不斷致力於新產品的研發，以提升自己的市場地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章類器官和球體市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 類器官和球體市場分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第 4 章 類型業務分析

  • 細分儀表板
  • 全球類器官與球體市場：類型變異分析
  • 2018-2030 年全球類器官及球體市場規模及趨勢分析（按類型）
  • 類器官
    • 類器官依類型
    • 依方法分類的類器官
    • 類器官依來源分類
  • 球體
    • 按類型分類的球體
    • 球體的方法
    • 按來源分類的球體

第5章 最終用途業務分析

  • 細分儀表板
  • 全球類器官和球體市場：最終用途變化分析
  • 2018-2030 年全球類器官及球體市場規模及最終用途趨勢分析
  • 生物技術和製藥業
  • 學術研究所
  • 醫院和診斷中心

第6章 應用業務分析

  • 細分儀表板
  • 全球類器官和球體市場：應用變化分析
  • 2018-2030 年全球類器官和球體市場規模和趨勢分析（按應用）
  • 發育生物學
    • 2018年至2030年發育生物學市場估計與預測
  • 個人化醫療
    • 個人化醫療市場估計與預測
  • 再生醫學
    • 2018年至2030年再生醫學市場估計與預測
  • 疾病病理學研究
    • 2018年至2030年疾病病理學研究市場估計與預測
  • 藥物毒性及藥效測試
    • 2018-2030年藥物毒效檢測市場預估及預測

第 7 章：按國家、類型、應用和最終用途進行的區域業務分析

  • 細分儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Lonza
    • 3D Biomatrix
    • 3D Biotek LLC
    • AMS Biotechnology（Europe）Limited
    • Cellesce Ltd
    • Corning Incorporated
    • Greiner Bio-One
    • Hubrecht Organoid Technology（HUB）
    • InSphero
    • Prellis Biologics
    • STEMCELL Technologies Inc.
Product Code: GVR-4-68038-843-5

Organoids And Spheroids Market Growth & Trends:

The global organoids and spheroids market size is expected to reach USD 3.26 billion by 2030, registering a CAGR of 23.11% during the forecast period, according to a new report by Grand View Research, Inc., A rise in the adoption of organoid cultures in drug discovery, and rising demand for cell therapy and tissue engineering across the globe is expected to drive the market.

3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.

A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.

Organoids And Spheroids Market Report Highlights:

  • The spheroids segment is anticipated to dominate the market throughout the analysis period
  • Higher adoption of 3D spheroids in the fields of drug discovery, disease modeling, and safety testing is a key factor driving the segment
  • The developmental biology application segment accounted for the largest revenue share in 2023 as the development of organoids from Induced Pluripotent Stem Cells (iPSCs) have paved way for dynamic observation of cell development and propelled the adoption of mechanistic studies for human development
  • Biotechnology and pharmaceutical industries dominated the end-use segment in the market in 2023. This is because of the high utilization rate of organoids and spheroids in pre-clinical drug discovery by pharma entities
  • In addition, these players are actively involved in the development of advanced products that enhance the efficiency of organoid and spheroid generation.
  • In North America, the market generated the highest revenue in 2023 due to higher adoption of technologically advanced cell culture platforms, and the presence of a large number of universities and academic institutions actively involved in cell and organ-based studies
  • In addition, a higher adoption rate of organoid and spheroid culture products and efficient healthcare infrastructure in North America is attributive to the largest revenue generation from the region
  • In Asia Pacific, the market is anticipated to witness lucrative growth over the forecast period.
  • Presence of key players and government organizations such as STEMCELL Technologies, Australasian Society for Stem Cell Research (ASSCR), The Japanese Society for Regenerative Medicine, The Korean Society for Stem Cell Research (KSSCR), and others are expected to enhance the penetration of organoid and spheroid culture in Asia
  • The key players are constantly involved in research and development of new products so that they can enhance their market position

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End-Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Organoids & Spheroids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High adoption of organoids & spheroids in drug discovery
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising demand for tissue engineering & organ transplantation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges associated with 3D cell culturing
      • 3.2.2.2. Ethical issues associated with organoid & spheroid cultures
  • 3.3. Organoids & Spheroids Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Organoids & Spheroids Market: Type Movement Analysis
  • 4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Organoids
    • 4.4.1. Organoids market estimates and forecast, 2018 - 2030
    • 4.4.2. Organoids by Type
      • 4.4.2.1. Neural Organoids
      • 4.4.2.1.1. Neural organoids market estimates and forecast, 2018 - 2030
      • 4.4.2.2. Hepatic Organoids
      • 4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018 - 2030
      • 4.4.2.3. Intestinal organoids
      • 4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018 - 2030
      • 4.4.2.4. Other organoids
      • 4.4.2.4.1. Other organoids market estimates and forecast, 2018 - 2030
    • 4.4.3. Organoids by Method
      • 4.4.3.1. General Submerged Method for Organoid Culture
      • 4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018 - 2030
      • 4.4.3.2. Crypt Organoid Culture Techniques
      • 4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018 - 2030
      • 4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
      • 4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018 - 2030
      • 4.4.3.4. Clonal Organoids from Lgr5+ Cells
      • 4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
      • 4.4.3.5. Brain and Retina Organoid Formation Protocol
      • 4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
      • 4.4.3.6. Others
      • 4.4.3.6.1. Others market estimates and forecast, 2018 - 2030
    • 4.4.4. Organoids by Source
      • 4.4.4.1. Primary Tissues
      • 4.4.4.1.1. Primary tissues market estimates and forecast, 2018 - 2030
      • 4.4.4.2. Stem Cells
      • 4.4.4.2.1. Stem cells market estimates and forecast, 2018 - 2030
  • 4.5. Spheroids
    • 4.5.1. Spheroids market estimates and forecast, 2018 - 2030
    • 4.5.2. Spheroids by Type
      • 4.5.2.1. Multicellular tumor spheroids (MCTS)
      • 4.5.2.1.1. MCTS market estimates and forecast, 2018 - 2030
      • 4.5.2.2. Neurospheres
      • 4.5.2.2.1. Neurospheres market estimates and forecast, 2018 - 2030
      • 4.5.2.3. Mammospheres
      • 4.5.2.3.1. Mammospheres market estimates and forecast, 2018 - 2030
      • 4.5.2.4. Hepatospheres
      • 4.5.2.4.1. Hepatospheres market estimates and forecast, 2018 - 2030
      • 4.5.2.5. Embryoid bodies
      • 4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018 - 2030
    • 4.5.3. Spheroids by Method
      • 4.5.3.1. Micropatterned Plates
      • 4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018 - 2030
      • 4.5.3.2. Low Cell Attachment Plates
      • 4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018 - 2030
      • 4.5.3.3. Hanging Drop Method
      • 4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018 - 2030
      • 4.5.3.4. Others
      • 4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018 - 2030
    • 4.5.4. Spheroids by Source
      • 4.5.4.1. Cell Line
      • 4.5.4.1.1. Cell line market estimates and forecast, 2018 - 2030
      • 4.5.4.2. Primary Cell
      • 4.5.4.2.1. Primary cell market estimates and forecast, 2018 - 2030
      • 4.5.4.3. iPSCs Derived Cells
      • 4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018 - 2030

Chapter 5. End-Use Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
  • 5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Biotechnology and Pharmaceutical Industries
    • 5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
  • 5.5. Academic & Research Institutes
    • 5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Hospitals and Diagnostic Centers
    • 5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)

Chapter 6. Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Organoids & Spheroids Market: Application Movement Analysis
  • 6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Developmental Biology
    • 6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
  • 6.5. Personalized Medicine
    • 6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Regenerative Medicine
    • 6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
  • 6.7. Disease Pathology Studies
    • 6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
  • 6.8. Drug Toxicity & Efficacy Testing
    • 6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Regional Business Analysis, by Country, Type, Application, & End-use

  • 7.1. Segment Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4. Europe
    • 7.4.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Target Disease Prevalence
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.2. China
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.3. Japan
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.6. Latin America
    • 7.6.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.6.3. Mexico
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.6.4. Argentina
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7. MEA
    • 7.7.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.3. South Africa
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Target Disease Prevalence
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Target Disease Prevalence
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Lonza
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. 3D Biomatrix
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. 3D Biotek LLC
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. AMS Biotechnology (Europe) Limited
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Cellesce Ltd
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Corning Incorporated
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Greiner Bio-One
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Hubrecht Organoid Technology (HUB)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. InSphero
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Prellis Biologics
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. STEMCELL Technologies Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Europe organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Germany organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 19 UK organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 UK organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 22 France organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 23 France organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 France organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 25 Italy organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Italy organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 28 Spain organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Spain organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 31 Sweden organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 32 Sweden organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Sweden organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 34 Norway organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 35 Norway organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Norway organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 37 Denmark organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 38 Denmark organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Denmark organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 40 APAC organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 41 APAC organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 APAC organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 43 APAC organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 44 China organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 45 China organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 China organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Japan organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 50 India organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 51 India organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 India organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 53 Thailand organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 54 Thailand organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Thailand organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Korea organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Korea organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 60 Australia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Australia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 62 Latin America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Latin America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Brazil organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 69 Mexico organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Mexico organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 72 Argentina organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Argentina organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa organoids and spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 South Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 85 UAE organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 UAE organoids and spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait organoids and spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait organoids and spheroids market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Kuwait organoids and spheroids market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Organoids and Spheroids: market outlook
  • Fig. 9 Organoids and Spheroids competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Organoids and Spheroids market driver impact
  • Fig. 13 Organoids and Spheroids market restraint impact
  • Fig. 14 Organoids and Spheroids market strategic initiatives analysis
  • Fig. 15 Organoids and Spheroids market: type movement analysis
  • Fig. 16 Organoids and Spheroids market: type outlook and key takeaways
  • Fig. 17 Neural organoids market estimates and forecast, 2018 - 2030
  • Fig. 18 Hepatic organoids market estimates and forecast, 2018 - 2030
  • Fig. 19 Intestinal organoids market estimates and forecast, 2018 - 2030
  • Fig. 20 Other organoids market estimates and forecast, 2018 - 2030
  • Fig. 21 General submerged method for organoid culture market estimates and forecast, 2018 - 2030
  • Fig. 22 Crypt organoid culture techniques market estimates and forecast, 2018 - 2030
  • Fig. 23 ALI method for organoid culture market estimates and forecast, 2018 - 2030
  • Fig. 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
  • Fig. 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
  • Fig. 26 Others Organoid Formation Protocol market estimates and forecast, 2018 - 2030
  • Fig. 27 Primary tissues market estimates and forecast, 2018 - 2030
  • Fig. 28 Stem cells market estimates and forecast, 2018 - 2030
  • Fig. 29 Spheroids market estimates and forecast, 2018 - 2030
  • Fig. 30 MCTS market estimates and forecast, 2018 - 2030
  • Fig. 31 Neurospheres market estimates and forecast, 2018 - 2030
  • Fig. 32 Mammospheres market estimates and forecast, 2018 - 2030
  • Fig. 33 Hepatospheres market estimates and forecast, 2018 - 2030
  • Fig. 34 Embryoid bodies market estimates and forecast, 2018 - 2030
  • Fig. 35 Micropatterned plates market estimates and forecast, 2018 - 2030
  • Fig. 36 Low cell attachment plates market estimates and forecast, 2018 - 2030
  • Fig. 37 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 38 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 39 Cell line market estimates and forecast, 2018 - 2030
  • Fig. 40 Primary cell market estimates and forecast, 2018 - 2030
  • Fig. 41 iPSCs derived cells market estimates and forecast, 2018 - 2030
  • Fig. 42 Organoids and spheroids market: end-use movement analysis
  • Fig. 43 Organoids and spheroids market: end-use outlook and key takeaways
  • Fig. 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018 - 2030
  • Fig. 45 Academic & research institutes market estimates and forecast, 2018 - 2030
  • Fig. 46 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
  • Fig. 47 Organoids and spheroids market: application movement analysis
  • Fig. 48 Organoids and spheroids market: application outlook and key takeaways
  • Fig. 49 Developmental biology market estimates and forecast, 2018 - 2030
  • Fig. 50 Personalized medicine market estimates and forecast, 2018 - 2030
  • Fig. 51 Regenerative medicine market estimates and forecast, 2018 - 2030
  • Fig. 52 Disease pathology studies market estimates and forecast, 2018 - 2030
  • Fig. 53 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
  • Fig. 54 Global Organoids and spheroids market: regional movement analysis
  • Fig. 55 Global Organoids and spheroids market: regional outlook and key takeaways
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecast, 2018 - 2030
  • Fig. 58 U.S. key country dynamics
  • Fig. 59 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 60 Canada key country dynamics
  • Fig. 61 Canada market estimates and forecast, 2018 - 2030
  • Fig. 62 Europe
  • Fig. 63 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 64 UK key country dynamics
  • Fig. 65 UK market estimates and forecast, 2018 - 2030
  • Fig. 66 Germany key country dynamics
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030
  • Fig. 68 France key country dynamics
  • Fig. 69 France market estimates and forecast, 2018 - 2030
  • Fig. 70 Italy key country dynamics
  • Fig. 71 Italy market estimates and forecast, 2018 - 2030
  • Fig. 72 Spain key country dynamics
  • Fig. 73 Spain market estimates and forecast, 2018 - 2030
  • Fig. 74 Sweden key country dynamics
  • Fig. 75 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 76 Norway key country dynamics
  • Fig. 77 Norway market estimates and forecast, 2018 - 2030
  • Fig. 78 Denmark key country dynamics
  • Fig. 79 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 80 Asia Pacific
  • Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 82 China key country dynamics
  • Fig. 83 China market estimates and forecast, 2018 - 2030
  • Fig. 84 Japan key country dynamics
  • Fig. 85 Japan market estimates and forecast, 2018 - 2030
  • Fig. 86 India key country dynamics
  • Fig. 87 India market estimates and forecast, 2018 - 2030
  • Fig. 88 Australia key country dynamics
  • Fig. 89 Australia market estimates and forecast, 2018 - 2030
  • Fig. 90 Thailand key country dynamics
  • Fig. 91 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 92 South Korea key country dynamics
  • Fig. 93 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 96 Brazil key country dynamics
  • Fig. 97 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 98 Mexico key country dynamics
  • Fig. 99 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 100 Argentina key country dynamics
  • Fig. 101 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 102 Middle East and Africa
  • Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 104 Saudi Arabia key country dynamics
  • Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 106 South Africa key country dynamics
  • Fig. 107 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 108 UAE key country dynamics
  • Fig. 109 UAE market estimates and forecast, 2018 - 2030
  • Fig. 110 Kuwait key country dynamics
  • Fig. 111 Kuwait market estimates and forecast, 2018 - 2030